All changes for the tissue urogenital system (236)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA640
Renal failure
Pathological
kidney
Human
—
SeriesMorbidity
DAA639
Kidney diseases
Pathological
kidney
Human
—
SeriesMorbidity
DAA626
Essential (primary) hypertension and hypertensive renal disease
Pathological
heart, kidney
Human
—
SeriesMorbidity
DAA620
Hypertensive heart and renal disease
Pathological
heart, kidney
Human
—
SeriesMorbidity
DAA605
Bladder cancer
Pathological
bladder
Human
—
SeriesMorbidity
DAA604
Cancer of kidney and renal pelvis
Pathological
urinary system
Human
—
SeriesMorbidity
DAA603
Prostate cancer
Pathological
prostate
Human
—
SeriesMorbidity
DAA602
Ovarian cancer
Pathological
ovary
Human
—
SeriesMorbidity
DAA601
Cancer of corpus uteri and uterus, part unspecified
Pathological
uterus
Human
—
SeriesMorbidity
DAA600
Cervical cancer
Pathological
cervix
Human
—
SeriesMorbidity
DAA599
Breast cancer
Pathological
mammary gland
Human
—
SeriesMorbidity
DAA291
chromosome 1 open reading frame 162
Molecular
kidney
Human
C1orf162
37.0% Increase Gene Expression Level
DAA290
lysozyme (renal amyloidosis)
Molecular
kidney
Human
LYZ
57.0% Increase Gene Expression Level
DAA289
brain protein 44-like
Molecular
kidney
Human
BRP44L
9.0% Decrease Gene Expression Level
DAA288
complement component 1, r subcomponent
Molecular
kidney
Human
C1R
21.0% Increase Gene Expression Level
DAA287
creatine kinase, brain
Molecular
kidney
Human
CKB
10.0% Decrease Gene Expression Level
DAA286
StAR-related lipid transfer (START) domain containing 8
Molecular
kidney
Human
STARD8
14.0% Decrease Gene Expression Level
DAA285
immunoglobulin kappa variable 1-5
Molecular
kidney
Human
IGKV1-5
35.0% Increase Gene Expression Level
DAA284
immunoglobulin lambda variable 4-3
Molecular
kidney
Human
IGLV4-3
41.0% Increase Gene Expression Level
DAA283
lactotransferrin
Molecular
kidney
Human
LTF
115.0% Increase Gene Expression Level
DAA282
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5
Molecular
kidney
Human
SERPINA5
11.0% Decrease Gene Expression Level
DAA281
coiled-coil domain containing 3
Molecular
kidney
Human
CCDC3
19.0% Increase Gene Expression Level
DAA280
FXYD domain containing ion transport regulator 2
Molecular
kidney
Human
FXYD2
5.0% Decrease Gene Expression Level
DAA279
nicotinamide N-methyltransferase
Molecular
kidney
Human
NNMT
40.0% Increase Gene Expression Level
DAA278
Ras-related GTP binding D
Molecular
kidney
Human
RRAGD
14.0% Decrease Gene Expression Level
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA640 | Renal failure | Pathological | kidney | Human | — | SeriesMorbidity | |
DAA639 | Kidney diseases | Pathological | kidney | Human | — | SeriesMorbidity | |
DAA626 | Essential (primary) hypertension and hypertensive renal disease | Pathological | heart, kidney | Human | — | SeriesMorbidity | |
DAA620 | Hypertensive heart and renal disease | Pathological | heart, kidney | Human | — | SeriesMorbidity | |
DAA605 | Bladder cancer | Pathological | bladder | Human | — | SeriesMorbidity | |
DAA604 | Cancer of kidney and renal pelvis | Pathological | urinary system | Human | — | SeriesMorbidity | |
DAA603 | Prostate cancer | Pathological | prostate | Human | — | SeriesMorbidity | |
DAA602 | Ovarian cancer | Pathological | ovary | Human | — | SeriesMorbidity | |
DAA601 | Cancer of corpus uteri and uterus, part unspecified | Pathological | uterus | Human | — | SeriesMorbidity | |
DAA600 | Cervical cancer | Pathological | cervix | Human | — | SeriesMorbidity | |
DAA599 | Breast cancer | Pathological | mammary gland | Human | — | SeriesMorbidity | |
DAA291 | chromosome 1 open reading frame 162 | Molecular | kidney | Human | C1orf162 | 37.0% Increase Gene Expression Level | |
DAA290 | lysozyme (renal amyloidosis) | Molecular | kidney | Human | LYZ | 57.0% Increase Gene Expression Level | |
DAA289 | brain protein 44-like | Molecular | kidney | Human | BRP44L | 9.0% Decrease Gene Expression Level | |
DAA288 | complement component 1, r subcomponent | Molecular | kidney | Human | C1R | 21.0% Increase Gene Expression Level | |
DAA287 | creatine kinase, brain | Molecular | kidney | Human | CKB | 10.0% Decrease Gene Expression Level | |
DAA286 | StAR-related lipid transfer (START) domain containing 8 | Molecular | kidney | Human | STARD8 | 14.0% Decrease Gene Expression Level | |
DAA285 | immunoglobulin kappa variable 1-5 | Molecular | kidney | Human | IGKV1-5 | 35.0% Increase Gene Expression Level | |
DAA284 | immunoglobulin lambda variable 4-3 | Molecular | kidney | Human | IGLV4-3 | 41.0% Increase Gene Expression Level | |
DAA283 | lactotransferrin | Molecular | kidney | Human | LTF | 115.0% Increase Gene Expression Level | |
DAA282 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | Molecular | kidney | Human | SERPINA5 | 11.0% Decrease Gene Expression Level | |
DAA281 | coiled-coil domain containing 3 | Molecular | kidney | Human | CCDC3 | 19.0% Increase Gene Expression Level | |
DAA280 | FXYD domain containing ion transport regulator 2 | Molecular | kidney | Human | FXYD2 | 5.0% Decrease Gene Expression Level | |
DAA279 | nicotinamide N-methyltransferase | Molecular | kidney | Human | NNMT | 40.0% Increase Gene Expression Level | |
DAA278 | Ras-related GTP binding D | Molecular | kidney | Human | RRAGD | 14.0% Decrease Gene Expression Level |